Judge Tosses Preempted Claims From Aredia Suits
Playing the federal-law trump card, Novartis Pharmaceuticals Corp. has prevailed in its continuing bid to toss failure-to-warn claims from cases in the multidistrict litigation over its bone cancer drugs Aredia and...To view the full article, register now.
Already a subscriber? Click here to view full article